EP3972960
Kristölluð form af BTK-hindra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.5.2020EP published:
24.12.2025EP application number:
20729201.2
EP translation filed:
4.3.2026Grant published:
8.4.2026EPO information:
European Patent Register
Max expiry date:
19.5.2040Expiry date:
19.5.2027Next due date:
31.5.2027
Title in English:
CRYSTALLINE FORMS OF A BTK INHIBITORLanguage of the patent:
English
Timeline
Today
20.5.2020EP application
24.12.2025EP Publication
4.3.2026Translation submitted
8.4.2026Registration published
19.5.2027Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
ANGST, DanielaAddress:
4002 Basel, CH
Name:
KORDIKOWSKI, AndreasAddress:
4002 Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962851986 PDate:
23.5.2019Country:
US
Classification
Categories:
C07D 239/47, A61P 35/00, A61K 31/505
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 2.3.2026
Expires: 19.5.2027
Payer: Árnason Faktor ehf.